IMMUNO-BIOLOGICAL LABORATORIES CO revenue for the last year amounted to 790.00 M JPY, the most of which — 790.60 M JPY — came from its highest performing source at the moment, Antibody-Related, the year earlier bringing 634.22 M JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought IMMUNO-BIOLOGICAL LABORATORIES CO 537.89 M JPY, and the year before that — 490.31 M JPY.